Skip to content
Biodatica
Start free

Investigator

Janey L Wiggs

MASSACHUSETTS EYE AND EAR INFIRMARY · funded by NEI

Companies
6

Resolved onto their grants.

Grants
6

Federal awards on file.

Non-dilutive funding
$1.9M

Summed across those awards.

First award
Apr 1, 2002

Latest Sep 30, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Genetic profiling of childhood glaucoma in India

    $361k

    Sep 30, 2024NEIMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11181502 (opens the source filing in a new tab)

  2. R01

    NEIGHBORHOOD Consortium for POAG Genetics

    $395k

    Aug 1, 2012NEIMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11018575 (opens the source filing in a new tab)

  3. R01

    Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma

    $426k

    Sep 1, 2011NEIMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11138698 (opens the source filing in a new tab)

  4. P30

    P-30 Admin Core

    $16k

    Apr 1, 2002NEIMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11181607 (opens the source filing in a new tab)

  5. P30

    P30 Core Grant for Vision Research

    $570k

    Apr 1, 2002NEIMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11181605 (opens the source filing in a new tab)

  6. P30

    Biobank Core

    $128k

    Apr 1, 2002NEIMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11181608 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources